SWM
RVPH

Spire Wealth Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Spire Wealth Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-60
Closed -$2.17K – 2564
2024
Q4 		$2.17K Buy
+60
New +$1.67K ﹤0.01% 2235

Other funds holding RVPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Spire Wealth Management's RVPH Position: Q1 2025 in Review

Spire Wealth Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2025, closing a stake of 60 shares — an estimated $2.17K sold.

Spire Wealth Management first reported a position in RVPH in Q4 2024 and held it in 1 quarter. The position peaked at $2.17K in Q4 2024. 48 funds tracked by Wall St. Rank hold RVPH as of Q1 2025.

  • Spire Wealth Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2025 after selling out during the quarter.
  • Spire Wealth Management sold 60 REVIVA PHARMA HLDGS INC shares in Q1 2025, an estimated $2.17K.
  • Spire Wealth Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2024 and held it in 1 quarter.
  • Spire Wealth Management's REVIVA PHARMA HLDGS INC position peaked at $2.17K in Q4 2024.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2025.

Based on Spire Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.